Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Pharma in Focus Jobs
Farmaforce
PMPConnect
Latest News
Industry lays out agenda as Hunt aims for 'world's best health system'
New Minister: Australia's medicines industry yesterday clambered to welcome newly appointed minister Greg Hunt to the health portfolio, with numerous advocacy groups indicating they would soon be knocking on his door.
Media off track on pharma-patient ties
Reputation: Mainstream media reporting of calls by by Australian researchers for greater transparency around industry funding of patient groups appears to be unaware of MA's work with the Consumers Health Forum.
OECD gets tough on drug costs
Reimbursement: The solution to spending too much on high-cost meds is to allow payers the power to 'adjust prices and withdraw payment' says world economic body.
Pharma deals boost MedAdvisor
Patient Engagement: Industry sponsored programs help drive big increase in quarterly operating cash receipts for e-health service provider.
Most Popular
Eli Lilly brings in new ANZ boss
Leadership: Fifteen year veteran of the company Margaret 'Libby' Driscoll expected to take up the new role sometime in Q1 moving from her current position as GM for Taiwan.
Arrow reps go in 'realignment'
Employment: After its first year in operation, local generic business Arrow, has reduced its direct sales force.
Ley quits ministry over expenses
Leadership: Prime Minister Malcolm Turnbull announces Sussan Ley's departure following receipt of a report into her contentious expenses claims - and also announces sweeping changes to ministerial expenses regulation.
Class action wants more millions from RB
Litigation: A looming class action, whose claims will be heard in early February, could potentially cost Reckitt Benckiser tens of millions of dollars on top of the $6 million fine already secured by the ACCC.
Resubmissions pile up for March PBAC
Reimbursement: The PBAC has been asked to reconsider eight major decisions from previous meetings when it next meets in March 2017.
Earlier
Health gets World's Best Minister
Leadership: Industry, Innovation and Science Minister Greg Hunt has been named as the new Federal Health Minister, replacing Sussan Ley.
GSK appoints regional chief
Leadership: Frenchman Herve Gisserot takes on newly-recreated role after shepherding GSK's Chinese operation through a lengthy government pricing investigation which hit the company with a record $542 million fine.
Gilead now receiving 17% of PBS
Reimbursement: Official PBS spending figures for the year to November show that 16.9 per cent of total outlays for most of 2016 paid for drugs sponsored by Gilead.
Label warnings inconsistent study finds
Medicines Safety: A study investigating label information and warnings for four cardiovascular risks in ADHD meds has found that both health professional and consumer labelling provided inconsistent information.
Debating Point
How much damage could Trump do to pharma?
With only a couple of days to go until Donald Trump is inaugurated as the 45th President of the United States, his tendency to bash pharma has many worried. Could he damage the US industry enough to affect Australia?
Approvals Action
Allergan's new acne product and new generics
This week we cover new registrations since 19 December 2016, including new products from Allergan and AbbVie, and first-time competition for SciGen's epilepsy treatment Zonegran.
Pipeline Monitor
Approvals and recommendations in cancer and RA
The FDA approves a highly targeted ovarian cancer drug and AbbVie files its once-daily hepatitis C combination in the US in our final pipeline roundup for 2016.
Special Report
PBAC March agenda in full
The PBAC will consider 33 submissions from sponsor companies next March at its first meeting for 2017 plus six reports from the Drug Utilisation Sub-Committee.
FREE Content
Events & Conferences
SEARCH NOW
Pharma in Focus Jobs
Ascott Sales